Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Donaldson

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|October 23, 2013
Investigating Clostridium difficileLuke Sp Moore, Hugo Donaldson
British Journal of Hospital Medicine (London, England : 2005)|November 26, 2013
Investigating Clostridium difficileLuke S P Moore, Hugo Donaldson
The Journal of Infection|March 21, 2014
GeneXpert(®) MTB/RIF in low prevalence settings: a UK laboratory perspectiveAnika Singanayagam, Hugo Donaldson, Onn Min Kon
British Journal of Hospital Medicine (London, England : 2005)|April 14, 2016
A clinical approach to managing Pseudomonas aeruginosa infectionsLuke Sp Moore, Joel Cunningham, Hugo Donaldson
Journal of Neurology, Neurosurgery, and Psychiatry|August 2, 2012
Neurological picture. Multiple intracranial abscesses due to Streptococcus anginosus in a previously well individualMatthew Anthony Kirkman, Hugo Donaldson, Kevin O'Neill
American Journal of Infection Control|February 19, 2015
Evolution of antibiotic resistance in bacteria involved in urinary tract infections: a 3-year London experiencePaul Jones, Luke S P Moore, Hugo Donaldson
British Journal of Hospital Medicine (London, England : 2005)|August 10, 2012
Using infection specialistsLuke S P Moore, James Hatcher, Hugo Donaldson
The Lancet. Infectious Diseases|February 13, 2016
Plasmid-mediated colistin resistance mechanisms: is it time to revise our approach to selective digestive decontamination?Timothy Miles Rawson, Luke Stephen Prockter Moore, James Christopher Hatcher, et al.
Emerging Infectious Diseases|June 25, 2014
Lessons for control of heroin-associated anthrax in Europe from 2009-2010 outbreak case studies, London, UKAula Abbara, Tim Brooks, Graham P Taylor, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2025
Comment on: Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?Timothy M Rawson, Maxwell Al-Hassan, Ilona Brzeska-Trafny, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Hospital Medicine (London, England : 2005)|October 23, 2013
Investigating Clostridium difficileLuke Sp Moore, Hugo Donaldson
British Journal of Hospital Medicine (London, England : 2005)|November 26, 2013
Investigating Clostridium difficileLuke S P Moore, Hugo Donaldson
The Journal of Infection|March 21, 2014
GeneXpert(®) MTB/RIF in low prevalence settings: a UK laboratory perspectiveAnika Singanayagam, Hugo Donaldson, Onn Min Kon
British Journal of Hospital Medicine (London, England : 2005)|April 14, 2016
A clinical approach to managing Pseudomonas aeruginosa infectionsLuke Sp Moore, Joel Cunningham, Hugo Donaldson
Journal of Neurology, Neurosurgery, and Psychiatry|August 2, 2012
Neurological picture. Multiple intracranial abscesses due to Streptococcus anginosus in a previously well individualMatthew Anthony Kirkman, Hugo Donaldson, Kevin O'Neill
American Journal of Infection Control|February 19, 2015
Evolution of antibiotic resistance in bacteria involved in urinary tract infections: a 3-year London experiencePaul Jones, Luke S P Moore, Hugo Donaldson
British Journal of Hospital Medicine (London, England : 2005)|August 10, 2012
Using infection specialistsLuke S P Moore, James Hatcher, Hugo Donaldson
The Lancet. Infectious Diseases|February 13, 2016
Plasmid-mediated colistin resistance mechanisms: is it time to revise our approach to selective digestive decontamination?Timothy Miles Rawson, Luke Stephen Prockter Moore, James Christopher Hatcher, et al.
Emerging Infectious Diseases|June 25, 2014
Lessons for control of heroin-associated anthrax in Europe from 2009-2010 outbreak case studies, London, UKAula Abbara, Tim Brooks, Graham P Taylor, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2025
Comment on: Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?Timothy M Rawson, Maxwell Al-Hassan, Ilona Brzeska-Trafny, et al.
Pageof 3